Dietary supplements for cholesterol management

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Dietary supplements are widely marketed and available to health-care consumers who wish to lower their cholesterol levels. As dietary supplements are not considered drugs, there is a lack of regulation in their production and also a deficiency of appropriately designed trials demonstrating their efficacy and safety when used alone or in combination with prescription medications. However, using supplements in place of or in addition to prescribed cholesterol-lowering therapies may be more aligned with the patient’s value system or health-care philosophy. Dietary supplements, such as red yeast rice (RYR), have been shown to have the same mode of action as prescription cholesterol-lowering therapies like 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors. While others, like soluble dietary fiber (SDF), have multiple proposed modes of action. Reasonable data exist to support the use of dietary supplements—in addition to lifestyle modification—as an alternative, or add-on therapy, in those who are unable or unwilling to take conventional lipid-lowering agents.

Original languageEnglish (US)
Title of host publicationDyslipidemias: Pathophysiology, Evaluation and Management
PublisherHumana Press Inc.
Pages383-402
Number of pages20
ISBN (Print)9781607614241, 9781607614234
DOIs
StatePublished - Jan 1 2015

Fingerprint

Dietary Cholesterol
Dietary Supplements
Cholesterol
Prescriptions
Delivery of Health Care
Dietary Fiber
Life Style
Oxidoreductases
Therapeutics
Lipids
Safety
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Almandoz, J. P. (2015). Dietary supplements for cholesterol management. In Dyslipidemias: Pathophysiology, Evaluation and Management (pp. 383-402). Humana Press Inc.. https://doi.org/10.1007/978-1-60761-424-1_23

Dietary supplements for cholesterol management. / Almandoz, Jaime P.

Dyslipidemias: Pathophysiology, Evaluation and Management. Humana Press Inc., 2015. p. 383-402.

Research output: Chapter in Book/Report/Conference proceedingChapter

Almandoz, JP 2015, Dietary supplements for cholesterol management. in Dyslipidemias: Pathophysiology, Evaluation and Management. Humana Press Inc., pp. 383-402. https://doi.org/10.1007/978-1-60761-424-1_23
Almandoz JP. Dietary supplements for cholesterol management. In Dyslipidemias: Pathophysiology, Evaluation and Management. Humana Press Inc. 2015. p. 383-402 https://doi.org/10.1007/978-1-60761-424-1_23
Almandoz, Jaime P. / Dietary supplements for cholesterol management. Dyslipidemias: Pathophysiology, Evaluation and Management. Humana Press Inc., 2015. pp. 383-402
@inbook{1b6046bcc93d4623a1433dfa19d94c92,
title = "Dietary supplements for cholesterol management",
abstract = "Dietary supplements are widely marketed and available to health-care consumers who wish to lower their cholesterol levels. As dietary supplements are not considered drugs, there is a lack of regulation in their production and also a deficiency of appropriately designed trials demonstrating their efficacy and safety when used alone or in combination with prescription medications. However, using supplements in place of or in addition to prescribed cholesterol-lowering therapies may be more aligned with the patient’s value system or health-care philosophy. Dietary supplements, such as red yeast rice (RYR), have been shown to have the same mode of action as prescription cholesterol-lowering therapies like 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors. While others, like soluble dietary fiber (SDF), have multiple proposed modes of action. Reasonable data exist to support the use of dietary supplements—in addition to lifestyle modification—as an alternative, or add-on therapy, in those who are unable or unwilling to take conventional lipid-lowering agents.",
author = "Almandoz, {Jaime P.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-1-60761-424-1_23",
language = "English (US)",
isbn = "9781607614241",
pages = "383--402",
booktitle = "Dyslipidemias: Pathophysiology, Evaluation and Management",
publisher = "Humana Press Inc.",

}

TY - CHAP

T1 - Dietary supplements for cholesterol management

AU - Almandoz, Jaime P.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Dietary supplements are widely marketed and available to health-care consumers who wish to lower their cholesterol levels. As dietary supplements are not considered drugs, there is a lack of regulation in their production and also a deficiency of appropriately designed trials demonstrating their efficacy and safety when used alone or in combination with prescription medications. However, using supplements in place of or in addition to prescribed cholesterol-lowering therapies may be more aligned with the patient’s value system or health-care philosophy. Dietary supplements, such as red yeast rice (RYR), have been shown to have the same mode of action as prescription cholesterol-lowering therapies like 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors. While others, like soluble dietary fiber (SDF), have multiple proposed modes of action. Reasonable data exist to support the use of dietary supplements—in addition to lifestyle modification—as an alternative, or add-on therapy, in those who are unable or unwilling to take conventional lipid-lowering agents.

AB - Dietary supplements are widely marketed and available to health-care consumers who wish to lower their cholesterol levels. As dietary supplements are not considered drugs, there is a lack of regulation in their production and also a deficiency of appropriately designed trials demonstrating their efficacy and safety when used alone or in combination with prescription medications. However, using supplements in place of or in addition to prescribed cholesterol-lowering therapies may be more aligned with the patient’s value system or health-care philosophy. Dietary supplements, such as red yeast rice (RYR), have been shown to have the same mode of action as prescription cholesterol-lowering therapies like 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors. While others, like soluble dietary fiber (SDF), have multiple proposed modes of action. Reasonable data exist to support the use of dietary supplements—in addition to lifestyle modification—as an alternative, or add-on therapy, in those who are unable or unwilling to take conventional lipid-lowering agents.

UR - http://www.scopus.com/inward/record.url?scp=84956795079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956795079&partnerID=8YFLogxK

U2 - 10.1007/978-1-60761-424-1_23

DO - 10.1007/978-1-60761-424-1_23

M3 - Chapter

AN - SCOPUS:84956795079

SN - 9781607614241

SN - 9781607614234

SP - 383

EP - 402

BT - Dyslipidemias: Pathophysiology, Evaluation and Management

PB - Humana Press Inc.

ER -